Timeliness and actionable intelligence over I-Banks research which remains only geared to institutional investors and legacy processes. News carries with it a promise of transparency, a light that can be shined into previously dark corners.
But they don’t define any relevance to the actual value of a release - mostly due to SEC forward looking parameters. However, this news portal has been expanded to … supplement, measure and price the event and relevance to a company’s ... valuation.
January 2, 2020
Happy New Year – 2020
December 22, 2019
Happy Hanukkah and a Merry Christmas as the NEW Year 2020 approaches
November 28, 2019
Happy Thanksgiving ... giving thanks and be SAFE!
September 11, 2019
Remember and never forget!
August 8, 2019
Stemline Therapeutics (STML) proposes 5 M share offering
August 5, 2019
Regenerative Medicine Earnings Scorecard - Q2/19 - to date
April 8, 2019
Histogenics (HSGX) reverse mergers with Ocugen, Inc.
February 26, 2019
Sage Therapeutics (SAGE) prices 3.33 M share offering at $150.00
January 29, 2019
RegMed Investors’ (RMi) mid-day: bottoms bounce
January 21, 2019
RegMed Investors’ (RMi): worried about 2019, investors better be!
January 15, 2019
Alnylam Pharmaceuticals (ALNY) priced 5 M share offering at $77.50
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at email@example.com.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors